<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">70843</article-id><article-id pub-id-type="doi">10.7554/eLife.70843</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Rapid and sensitive detection of SARS-CoV-2 infection using quantitative peptide enrichment LC-MS analysis</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-232828"><name><surname>Hober</surname><given-names>Andreas</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8947-2562</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-243145"><name><surname>Tran-Minh</surname><given-names>Khue Hua</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-243146"><name><surname>Foley</surname><given-names>Dominic</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-243147"><name><surname>McDonald</surname><given-names>Thomas</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-243148"><name><surname>Vissers</surname><given-names>Johannes PC</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-243149"><name><surname>Pattison</surname><given-names>Rebecca</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf5"/></contrib><contrib contrib-type="author" id="author-243150"><name><surname>Ferries</surname><given-names>Samantha</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf6"/></contrib><contrib contrib-type="author" id="author-243151"><name><surname>Hermansson</surname><given-names>Sigurd</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf7"/></contrib><contrib contrib-type="author" id="author-243152"><name><surname>Betner</surname><given-names>Ingvar</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf8"/></contrib><contrib contrib-type="author" id="author-224590"><name><surname>Uhlén</surname><given-names>Mathias</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-243153"><name><surname>Razavi</surname><given-names>Morteza</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf9"/></contrib><contrib contrib-type="author" id="author-243154"><name><surname>Yip</surname><given-names>Richard</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf10"/></contrib><contrib contrib-type="author" id="author-243155"><name><surname>Pope</surname><given-names>Matthew E</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf11"/></contrib><contrib contrib-type="author" id="author-256529"><name><surname>Pearson</surname><given-names>Terry W</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf12"/></contrib><contrib contrib-type="author" id="author-243156"><name><surname>Andersson</surname><given-names>Leigh N</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf13"/></contrib><contrib contrib-type="author" id="author-243157"><name><surname>Bartlett</surname><given-names>Amy</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf14"/></contrib><contrib contrib-type="author" id="author-243158"><name><surname>Calton</surname><given-names>Lisa</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf15"/></contrib><contrib contrib-type="author" id="author-243159"><name><surname>Alm</surname><given-names>Jessica J</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-83444"><name><surname>Engstrand</surname><given-names>Lars</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-240476"><name><surname>Edfors</surname><given-names>Fredrik</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0017-7987</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution>Science for Life Laboratory</institution>, <addr-line><named-content content-type="city">Solna</named-content></addr-line>, <country>Sweden</country></aff><aff id="aff2"><institution>Royal Institute of Technology</institution>, <addr-line><named-content content-type="city">Solna</named-content></addr-line>, <country>Sweden</country></aff><aff id="aff3"><institution>Waters Corporation</institution>, <addr-line><named-content content-type="city">Milford</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff4"><institution>Waters Corporation</institution>, <addr-line><named-content content-type="city">Stockholm, Sweden</named-content></addr-line>, <country>Sweden</country></aff><aff id="aff5"><institution content-type="dept">Systems Biology</institution>, <institution>KTH Royal Institute of Technology</institution>, <addr-line><named-content content-type="city">Stockholm</named-content></addr-line>, <country>Sweden</country></aff><aff id="aff6"><institution>SISCAPA Assay Technologies, Inc</institution>, <addr-line><named-content content-type="city">Washington</named-content></addr-line>, <country>United States</country></aff><aff id="aff7"><institution>Karolinska Institutet</institution>, <addr-line><named-content content-type="city">Stockholm</named-content></addr-line>, <country>Sweden</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-162363"><name><surname>Dhaenens</surname><given-names>Maarten</given-names></name><role>Reviewing editor</role><aff><institution>ProGenTomics, Laboratory of Pharmaceutical Biotechnology, Ghent University, Ghent, Belgium</institution>, </aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>fredrik.edfors@scilifelab.se</email> (FE);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>08</day><month>11</month><year>2021</year></pub-date><volume>10</volume><elocation-id>e70843</elocation-id><history><date date-type="received"><day>31</day><month>05</month><year>2021</year></date><date date-type="accepted"><day>04</day><month>11</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Hober et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Hober et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-70843-v1.pdf"/><abstract><p>Reliable, robust, large-scale molecular testing for SARS-CoV-2 is essential for monitoring the ongoing Covid-19 pandemic. We have developed a scalable analytical approach to detect viral proteins based on peptide immunoaffinity enrichment combined with liquid chromatography - mass spectrometry (LC-MS). This is a multiplexed strategy, based on targeted proteomics analysis and read-out by LC-MS, capable of precisely quantifying and confirming the presence of SARS-CoV-2 in PBS swab media from combined throat/nasopharynx/saliva samples.&lt;br /&gt;The results reveal that the levels of SARS-CoV-2 measured by LC-MS correlate well with their corresponding RT-PCR readout (r=0.79). The analytical workflow shows similar turnaround times as regular RT-PCR instrumentation with a quantitative readout of viral proteins corresponding to cycle thresholds (Ct) equivalents ranging from 21 to 34. Using RT-PCR as a reference, we demonstrate that the LC-MS-based method has 100% negative percent agreement (estimated specificity) and 95% positive percent agreement (estimated sensitivity) when analyzing clinical samples collected from asymptomatic individuals with a Ct within the limit of detection of the mass spectrometer (Ct ≤30). These results suggest that a scalable analytical method based on LC-MS has a place in future pandemic preparedness centers to complement current virus detection technologies.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><funding-statement>No external funding was received for this work.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Dominic Foley, employed by Waters Corporation.</p></fn><fn fn-type="conflict" id="conf3"><p>Thomas McDonald, employed by Waters Corporation.</p></fn><fn fn-type="conflict" id="conf4"><p>Johannes PC Vissers, employed by Waters Corporation.</p></fn><fn fn-type="conflict" id="conf5"><p>Rebecca Pattison, employed by Waters Corporation.</p></fn><fn fn-type="conflict" id="conf6"><p>Samantha Ferries, employed by Waters Corporation.</p></fn><fn fn-type="conflict" id="conf7"><p>Sigurd Hermansson, employed by Waters Corporation.</p></fn><fn fn-type="conflict" id="conf8"><p>Ingvar Betner, employed by Waters Corporation.</p></fn><fn fn-type="conflict" id="conf9"><p>Morteza Razavi, employed by SISCAPA Assay Technologies.</p></fn><fn fn-type="conflict" id="conf10"><p>Richard Yip, employed by SISCAPA Assay Technologies.</p></fn><fn fn-type="conflict" id="conf11"><p>Matthew E Pope, employed by SISCAPA Assay Technologies.</p></fn><fn fn-type="conflict" id="conf12"><p>Terry W Pearson, employed by SISCAPA Assay Technologies.</p></fn><fn fn-type="conflict" id="conf13"><p>Leigh N Andersson, employed by SISCAPA Assay Technologies.</p></fn><fn fn-type="conflict" id="conf14"><p>Amy Bartlett, employed by Waters Corporation.</p></fn><fn fn-type="conflict" id="conf15"><p>Lisa Calton, employed by Waters Corporation.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: The study was performed in accordance with the declaration of Helsinki and the study protocol (&quot;Jämförande studier av Covid-19 smitta och antikroppssvar i olika grupper i samhället&quot;) was approved by the Ethical Review Board of Linköping, Sweden (Regionala etikprövningsnämnden, Linköping, DNR - 2020-06395). Informed consent and consent to publish, including consent to publish anonymized data, was obtained from all subjects.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>The ProteomeXchange ID for this dataset is PXD026366. The proteomics data have been deposited to Panorama Public (https://panoramaweb.org/sars-cov-2_siscapa.url; allowing for access to raw files and integrated peak areas from as well as visualization of all LC-MRM/MS chromatograms.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Edfors F et al</collab></person-group><year iso-8601-date="2021">2021</year><source>Rapid and sensitive detection of SARS-CoV-2 infection using quantitative peptide enrichment LC-MS analysis</source><ext-link ext-link-type="uri" xlink:href="http://proteomecentral.proteomexchange.org/cgi/GetDataset?ID=PXD026366">http://proteomecentral.proteomexchange.org/cgi/GetDataset?ID=PXD026366</ext-link><comment>PXD026366</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-70843-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>